Creating a Circular Structure Converting Marine Byproducts into High-Value Resources

HAEPAGEN transforms jellyfish into high-purity atelocollagen biomaterials, creating environmental and economic value through sustainable ESG greentech management.

01 · ESG VISION & MISSION

Turning Circularity into Performance

01

Sustainable Future through Marine Greentech

Building a sustainable circular ecosystem for marine bio-resources to deliver next-generation bio solutions for human and planetary health.

02

Turning Marine Nuisance into High-Value Materials

Resolving jellyfish overpopulation through proprietary eco-friendly biotech and transforming waste into high-value biomaterials for marine ecosystems and human health.

02 · 3 CORE PILLARS OF HAEPAGEN ESG

Three Core ESG Values

01ENVIRONMENTAL · E

Ocean Restoration & Eco-Process

Upcycling jellyfish overpopulation into bio-resources while using E-beam purification and streamlined patented processes to reduce harmful chemicals, energy consumption and raw-material loss.

02SOCIAL · S

Fishery Support & Regional Growth

Supporting fishery-loss reduction and coastal communities while pursuing regional biotechnology growth and jobs through the planned Hwasun production base, and providing low-immunogenicity biomaterials for human health.

03GOVERNANCE · G

Transparent R&D & Compliance

Strengthening objective R&D validation with GIST and KAERI while preparing quality, safety and ethical technology-management systems that consider relevant BGMP, CGMP and ISO standards.

03 · THE OCEAN-TO-VALUE CIRCULAR FRAMEWORK

Resource Circulation and ESG Value Creation

/01
STAGE 01 · MARINE WASTE COLLECT

Jellyfish Collection & Pre-Treatment

Rapid pre-treatment and salting of harvested jellyfish supports ecosystem protection, reduced fishery losses and coastal income opportunities.

/02
STAGE 02 · GREEN TECH PROCESSING

Eco-Friendly E-Beam & Patented Purification

E-beam treatment and precision telopeptide removal are designed to reduce harmful chemicals and pursue a lower-carbon process with a fourfold yield improvement through the patented process.

/03
STAGE 03 · HIGH-VALUE BIOMATERIAL

Ultra-Pure Atelocollagen

Low-immunogenicity collagen production transforms marine byproducts into high-value biomaterials with competitive cost potential.

/04
STAGE 04 · SUSTAINABLE PLATFORM

Global Bio Solutions

Expansion into derma cosmetics, nutraceuticals and regenerative biomaterials completes a circular marine-greentech platform for human and planetary health.

04 · ESG COMMITMENTS & TARGETS

HAEPAGEN ESG Commitments

01ECO-FRIENDLY MANUFACTURING

Eco-Friendly Manufacturing & Carbon Neutrality

Pursuing solvent-free purification through E-beam and enzyme processing, with plans for high-efficiency HVAC and eco-friendly equipment in the BGMP-aligned Hwasun smart production facility.

02REGIONAL PARTNERSHIP

Social Responsibility & Regional Partnership

Supporting coastal fishery environments through continuous jellyfish upcycling and fostering regional biotechnology talent and jobs through the Hwasun bio cluster.